Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Septerna, Inc.
Septerna Announces Selection of SEP-204 as Development Candidate for Graves’ Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting
November 4, 2026
Septerna to Participate in Upcoming Investor Conferences
November 3, 2026
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 10, 2026
Septerna to Participate in Upcoming Investor Conferences
September 1, 2026
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
August 25, 2026
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
August 10, 2026
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
May 11, 2026
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 9, 2026
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
March 9, 2026